JMP Securities Reaffirms Their Buy Rating on GH Research (GHRS)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on GH Research (GHRS – Research Report), with a price ...
JMP Securities Reaffirms Their Buy Rating on Roku (ROKU)
In a report released today, Matthew Condon from JMP Securities reiterated a Buy rating on Roku (ROKU – Research Report), with a price target of ...
JMP Securities maintains Roku stock with $95 target
JMP Securities reaffirmed its Market Outperform rating on Roku Inc. (NASDAQ:ROKU) with a steady price target of $95.00. According to InvestingPro data, Roku's stock has shown significant momentum with ...
JMP Securities maintains AN2 Therapeutics stock with $5 target
JMP Securities reiterated its Market Outperform rating on AN2 Therapeutics (NASDAQ:ANTX) shares, maintaining a $5.00 price target, representing significant upside from the current price of $1.14.
manilatimes1h
GH Research Announces Proposed Public Offering
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression. GH Research PLC's initial focus ...